Literature DB >> 29715098

The Combination of Flavokawain B and Daunorubicin Induces Apoptosis in Human Myeloid Leukemic Cells by Modifying NF-κB.

Jae Jin Lee1, Kyung-Nam Koh2, Chan-Jeoung Park3, Seongsoo Jang3, Ho Joon Im4, Nayoung Kim5.   

Abstract

BACKGROUND/AIM: Flavokawain B (FKB), is a natural chalcone isolated from kava root that induces apoptosis in cancer cells. Herein we investigated the effects of combination of FKB and daunorubicin (DNR) on human leukemic cells.
MATERIALS AND METHODS: Cell viability and death were assessed by the MTS assay and flow cytometry. NK-κB was detected by western blotting.
RESULTS: FKB alone and in combination with DNR reduced the viable cell numbers of four leukemic cell lines. FKB itself induced apoptosis of an acute myeloid cell line, HL-60. Because the additive effect of DNR and FKB was most obvious in HL-60 cells, subsequent experiments were performed with HL-60 cells. Combined treatment of the two compounds increased NF-κB activation at 12 h.
CONCLUSION: A combination treatment of DNR and FKB may improve the anticancer effects of DNR in DNR-resistant acute myeloid leukemia. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Flavokawain B; acute myeloid leukemia; daunorubicin

Mesh:

Substances:

Year:  2018        PMID: 29715098     DOI: 10.21873/anticanres.12520

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Astragaloside IV regulates NF-κB-mediated cellular senescence and apoptosis of hepatic stellate cells to suppress PDGF-BB-induced activation.

Authors:  Zhiwei Chen; Ling Yao; Yuanyuan Liu; Zheng Pan; Shuang Peng; Guoguo Wan; Junxiong Cheng; Jianwei Wang; Wenfu Cao
Journal:  Exp Ther Med       Date:  2019-09-25       Impact factor: 2.447

2.  Nuclear Lipid Microdomains Regulate Daunorubicin Resistance in Hepatoma Cells.

Authors:  Michela Codini; Carmela Conte; Samuela Cataldi; Cataldo Arcuri; Andrea Lazzarini; Maria Rachele Ceccarini; Federica Patria; Alessandro Floridi; Carmen Mecca; Francesco Saverio Ambesi-Impiombato; Tommaso Beccari; Francesco Curcio; Elisabetta Albi
Journal:  Int J Mol Sci       Date:  2018-11-01       Impact factor: 5.923

Review 3.  Kava as a Clinical Nutrient: Promises and Challenges.

Authors:  Tengfei Bian; Pedro Corral; Yuzhi Wang; Jordy Botello; Rick Kingston; Tyler Daniels; Ramzi G Salloum; Edward Johnston; Zhiguang Huo; Junxuan Lu; Andrew C Liu; Chengguo Xing
Journal:  Nutrients       Date:  2020-10-05       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.